Business Wire

I-VASC announces the first clinical use of VELEX™, the Empty Vein Ablation (EVA) technology device to treat Chronic Venous Insufficiency (CVI).

MILAN--(BUSINESS WIRE)--I-VASC, the Italy based start-up company which has developed and CE Marked its innovative percutaneous VELEX™ system to treat CVI, a condition that includes varicose veins ...
Business Wire

I-VASC Srl Announces achievement of 1,8M € Series A investment to launch its product, VELEX™, a device for the treatment of Chronic Venous Insufficiency (CVI)

MILAN--(BUSINESS WIRE)--The Series A round has seen the participation of former shareholders and a significant contribution of new investors: Italian business angels, family office and others. I-VASC ...
BioWorld

Vasc-Alert algorithm reliably predicts vascular access blockages in dialysis patients

Vasc-Alert LLC’s surveillance technology successfully predicts which dialysis patients are at risk of experiencing stenosis, a study published in the Journal of Vascular Access shows. Patients ...
Kaleido Scope

Passman, Marc A., M.D.

Dr. Marc A. Passman is a professor of surgery and currently serves as the director of the UAB Vein Program and UAB Vein Center. Dr. Passman is a board-certified specialist in vascular surgery, ...